Dario partners to integrate dexcom cgm data

New integration will improve access to dario's multi-chronic platform for more people living with diabetes new york , feb. 8, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) (the "company"), a leader in the global digital therapeutics (dtx) market, announced today an agreement with dexcom (nasdaq: dxcm), the global leader in real-time continuous glucose monitoring (cgm) technology, to integrate its market-leading cgms, into dario's multi-chronic condition platform.     dexcom cgm uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health.
DRIO Ratings Summary
DRIO Quant Ranking